RICE HALL JAMES & ASSOCIATES, LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1230765 San Diego, CA

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$39,964,145

+$10,668,915 QoQ

Shares Held

624,928

+2.7% QoQ

Ownership

0.400%

of shares outstanding

% of Portfolio

1.96%

of 13F equity value

Holder Rank

#17

of 264 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 84% Shared 0% None 16%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RICE HALL JAMES & ASSOCIATES, LLC holds $193,433,636 across 12 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (20.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc This page	624,928	$39,964,145
2	PBH	Prestige Consumer Healthcare Inc.	689,692	$32,601,740
3	BCRX	Biocryst Pharmaceuticals Inc	2,332,043	$23,320,430
4	SUPN	Supernus Pharmaceuticals, Inc.	490,221	$22,800,178
5	ALKS	Alkermes plc.	390,866	$20,481,378
6	NBIX	Neurocrine Biosciences Inc	100,195	$16,886,865
7	HROW	Harrow, Inc.	387,545	$16,459,036
8	EOLS	Evolus, Inc.	1,289,888	$8,951,822

All Filings in KNSA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$39,964,145	624,928	+2.7%	Shares	Sole	2026-08-07
2026-03-31	$29,295,230	608,416	+2.0%	Shares	Sole	2026-05-15
2025-12-31	$24,602,778	596,431	+3.2%	Shares	Sole	2026-02-17
2025-09-30	$22,436,828	577,822	-9.5%	Shares	Sole	2025-10-16
2025-06-30	$17,659,907	638,233	+2.2%	Shares	Sole	2025-08-11
2025-03-31	$13,871,144	624,545	-2.8%	Shares	Sole	2025-05-01
2024-12-31	$12,713,634	642,752	-1.1%	Shares	Sole	2025-01-31
2024-09-30	$16,234,253	649,630	+8.2%	Shares	Sole	2024-10-28
2024-06-30	$11,213,762	600,630	—	Shares	Sole	2024-08-07
No filing history on record for this holder in this stock.